Market Commentary For Sunday June 29 – Short Market Week + MNKD And Market Commentary. In this video, I explain why Afrezza is likely never to earn the money to justify a market cap higher than $500M for $MNKD. Additionally,…
Webinar June 27, 2014 Trading Illiquid Stocks
Webinar June 27, 2014 Trading Illiquid Stocks. I will update this during the week to actually show the order entries if I can figure out how to correctly edit it! In the mean time, this audio Webinar explains a few…
Video Market Commentary And Chart Reviews For Thurs June 26, 2014 – End Of Q Window Dressing
Video Market Commentary And Chart Reviews For Thurs June 26, 2014 – End Of Q Window Dressing. $ANAC, $ACRX, $HALO $INVE, $CYTK, and $VOLC charts reviewed. End of quarter window dressing should see the markets sell off early, come back…
Video Market Commentary For Tuesday June 24 – Profit Taking + Identive Antares And More
Market Commentary For Tuesday June 24 – Profit Taking + Identive Antares And More. I explain in part why I asked subs to study Identive before jumping in, and why both Callan and I like it. If you are invested…
Video Market Commentary For Sunday June 22 – Furtures Up Things Looking Good – For Now
Market Commentary For Sundsay June 22 – Furtures Up Things Looking Good – For Now. Some data this week includes – GDP, New and Existing homes sales and Jobless claims, so we need to watch those. I think GDP comes…
Bearish Premium Articles Bearish Premium Videos Bullish Premium Articles Bullish Premium Videos Commentary Premium Articles Commentary Premium Videos Premium Articles Premium Videos
Video Market Commentary For Thursday June 19 – INVE Long Term Winner, MNKD New Bear Info
Market Commentary For Thursday June 19 – INVE Long Term Winner, MNKD New Bear Info. INVE did well again today, but there is one market order seller that sells, fine. Dave has tried to ask Hart who he thinks that…
Activist Investor David Callan Has Been Accumulating Identiv Stock, Here is Why
Summary These days we hear about shareholder activism almost daily. It is next to impossible to watch CNBC and not hear discussions about some form of activism. Carl Icahn, Dan Loeb, Bill Ackman, George Soros or any of other…
Bearish Premium Articles Bearish Premium Videos Bullish Premium Articles Bullish Premium Videos Commentary Premium Articles Commentary Premium Videos Premium Articles Premium Videos
Market Commentary For Wed, June 18 – The Pump Continues With $MNKD
Market Commentary For Thursday June 18 – The Pump Continues With $MNKD. Commentary on Fed Policy meeting for 2 pm eastern later today Detailed Commentary on $MNKD, and why even if Afezza gets approval, it’s basically not worth much. Explanation…
Market Commentary For Monday June 16 – New Thesis’ Explained + Preview OF Callan Pick
Market Commentary For Monday June 16 – New Thesis’ Explained + Preview OF Callan Pick. $GEO commentary and chart review. $MNKD thesis explained plus I made a few adjustments to the report, so be sure to re-read it again! Also,…
Updated And Amended: Why Mannkind’s Afrezza Is No Blockbuster And Will Be Rejected By FDA
Updated 6/22: Cleaned up thesis to include that we feel the stock price will tank hard even if Afrezza is approved. Background and Story of Afreza MannKind Corporation (MNKD) is a biopharmaceutical company that focuses on the discovery, development, and…
